BRPI0415079A - biomarcadores para prognóstico de diarréia induzida por droga - Google Patents

biomarcadores para prognóstico de diarréia induzida por droga

Info

Publication number
BRPI0415079A
BRPI0415079A BRPI0415079-1A BRPI0415079A BRPI0415079A BR PI0415079 A BRPI0415079 A BR PI0415079A BR PI0415079 A BRPI0415079 A BR PI0415079A BR PI0415079 A BRPI0415079 A BR PI0415079A
Authority
BR
Brazil
Prior art keywords
biomarkers
prognosis
drug
induced diarrhea
diarrhea
Prior art date
Application number
BRPI0415079-1A
Other languages
English (en)
Inventor
Curt Douglas Wolfgang
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0415079A publication Critical patent/BRPI0415079A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"BIOMARCADORES PARA PROGNóSTICO DE DIARRéIA INDUZIDA POR DROGA". A presente invenção refere-se a biomarcadores para o prognóstico da diarréia com base na expressão genética de alguns genes pelo indivíduo, na expressão do tipo de sangue Diego pelo indivíduo, ou nos resultados das análises hematológicas.
BRPI0415079-1A 2003-10-06 2004-10-05 biomarcadores para prognóstico de diarréia induzida por droga BRPI0415079A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50897303P 2003-10-06 2003-10-06
PCT/EP2004/011122 WO2005039573A2 (en) 2003-10-06 2004-10-05 Biomarkers for the prediction of drug-induced diarrhoea

Publications (1)

Publication Number Publication Date
BRPI0415079A true BRPI0415079A (pt) 2006-12-12

Family

ID=34520004

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415079-1A BRPI0415079A (pt) 2003-10-06 2004-10-05 biomarcadores para prognóstico de diarréia induzida por droga

Country Status (9)

Country Link
US (1) US20070289889A1 (pt)
EP (1) EP1673631A2 (pt)
JP (1) JP2007509604A (pt)
CN (1) CN1875275A (pt)
AU (1) AU2004283428A1 (pt)
BR (1) BRPI0415079A (pt)
CA (1) CA2541097A1 (pt)
MX (1) MXPA06003826A (pt)
WO (1) WO2005039573A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005111605A2 (en) * 2004-05-17 2005-11-24 Novartis Ag Biomarkers for the prediction and treatment of drug-induced diarrhoea
EP1994412A2 (en) * 2006-03-31 2008-11-26 Brystol-Myers Squibb Company Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
CN103217534A (zh) * 2012-01-20 2013-07-24 上海市公共卫生临床中心 肺癌标志物sbp-1及其用途
CN108456725B (zh) * 2017-07-26 2019-06-21 湖北文理学院 Tm9sf1基因作为靶点在血管性疾病中的应用
CN109943640B (zh) * 2017-12-20 2021-08-03 华中农业大学 与母鸡储精能力相关的snp分子标记及其应用
WO2025114512A1 (en) * 2023-11-29 2025-06-05 Cnrs Dsi Therapeutic use of surf2 modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686479A (en) * 1985-07-22 1987-08-11 Young Chung C Apparatus and control kit for analyzing blood sample values including hematocrit
WO2000003024A2 (en) * 1998-07-10 2000-01-20 The Rockefeller University Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon
ATE469966T1 (de) * 2000-12-12 2010-06-15 Inst Nagoya Ind Science Res Verfahren zur abschätzung des risikos der expression einer durch die verabreichung einer verbindung, die entweder per se durch ugt1a1 metabolisiert wird oder deren zwischenverbindung durch das enzym metabolisiert wird, hervorgerufenen unerwünschten arzneimittelwirkung
CA2454643A1 (en) * 2001-07-23 2003-02-20 Epidauros Biotechnologie Ag Methods for the treatment of cancer with irinotecan based on cyp3a5

Also Published As

Publication number Publication date
JP2007509604A (ja) 2007-04-19
WO2005039573A2 (en) 2005-05-06
AU2004283428A1 (en) 2005-05-06
CN1875275A (zh) 2006-12-06
EP1673631A2 (en) 2006-06-28
WO2005039573A3 (en) 2006-02-16
MXPA06003826A (es) 2006-06-14
CA2541097A1 (en) 2005-05-06
US20070289889A1 (en) 2007-12-20

Similar Documents

Publication Publication Date Title
MY143215A (en) Multifocal lenses for pre-presbyopic individuals
BRPI0417107A (pt) fragmento de anticorpo, métodos de preparação do fragmento de anticorpo, ácido nucléico isolado, composições, célula hospedeira e métodos de fabricação e de geração de fragmento de anticorpo
ECSP055975A (es) Tinturas de cianina hidrofílicas, reactivas con tiol y conjugados de las mismas con biomoléculas para diagnóstico por fluorescencia
BR0212211A (pt) Diagnóstico de carcinomas
BR0300316A (pt) Método para selecionar uma fonte
DK1103564T3 (da) Cancerantigener baseret på tumorsuppressorgen WT1-produkt
BR9714927A (pt) Pneumático de serviço industrial
BRPI0606287A2 (pt) processo para a produção de silicones monofuncionais monodispersos e dispersos limitados
DE69906307D1 (de) Übergangsmetallkomplexe als linkergruppe
BRPI0415079A (pt) biomarcadores para prognóstico de diarréia induzida por droga
BRPI0417741A (pt) aldiminoalquilsilanos
BRPI0417992A (pt) método para purificar fsh
BR0212265A (pt) Método para a determinação de analisados múltiplos
BR0107861A (pt) Polissiloxanos para hidrofobização
WO2005000875A3 (en) Compositions and methods comprising a ligand of chemerin receptor
BR0111668A (pt) Liga de aço, ferramenta de moldagem plástica e blank temperado rijo para ferramentas de moldagem plástica
NO20024535L (no) Ventilasjonsventilsammensetning for stöpeformer
BRPI0513297A (pt) polipeptìdeo
CY1107335T1 (el) ΝΕΑ ΠΟΛΥΝΟΥΚΛΕΟΤΙΔΙΑ ΚΑΙ ΠΟΛΥΠΕΠΤΙΔΙΑ ΤΟΥ ΓΟΝΙΔΙΟΥ IFNα-17
BR0315178A (pt) Eritropoietina: remodelagem e glicoconjugação de eritropoietina
DE602004011481D1 (de) Kombinierung von mehreren unabhängigen Informationenquellen für die Klassifizierung von Prüflingen
BR0102431A (pt) Célula de têmpera com gás
BRPI0414365A (pt) composições, reagentes e kits para, e métodos de diagnosticar, monitorar e tratar obesidade e/ou diabetes
DE50213492D1 (de) Nukleinsäuresequenz, die für das OPCA Gen kodiert
ATE466958T1 (de) Klassifizierung von kolonkrebs

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.